All innovations, big and small, propel society forward.

Unfortunately, many innovative products fail in the market
for preventable reasons.

This cannot be allowed to happen.

We must seek out these companies,
bring them the right amount of expertise, leadership and capital,
and ensure that they achieve their potential.

Tech-Rx_Ventures_logo

A New Type of Venture Capital

Tech-Rx Ventures is a Special Purpose Fund with a unique investment strategy of helping young companies that require not only funding, but also critical management help and that meet these criteria–

Solvable Problems:  They have substantial business problems (beyond needing funds) that we are equipped to solve.
Committed Stakeholders:  Key stakeholders are committed and open to Tech-Rx Ventures augmenting their team and taking an active leadership role.
Working Technology:  Their product works and is truly innovative.
Market Fit:  They help to solve an important problem in a way that will have a meaningful impact on how people do business and lead their lives.
Exit Feasibility:  We see realistic exit opportunities within 3 years.

We consciously limit our investments to those companies where we believe we have significant advantages and can add extensive value beyond just capital, such as operating or board expertise.

We are not aware of any other venture groups targeting these types of companies.  Most investors target companies with a potential market of $1B+ and, if later stage, with complete management teams.  More often than not, these companies fail to meet expectations and investors lose interest, realizing a poor return.  We believe that many of these companies still present excellent opportunities, with lower risk than investing in embryonic start-ups, and a likelihood of excellent returns.  Our investment decisions contain fewer unknowns, because we have the benefit of knowledge not available at launch and can filter for companies with problems we believe we can solve.  We know that the technology works, the market response, the strengths and weaknesses, integrity and values of the current team, the operational effectiveness of the company, plus what has and has not worked previously.

We create investment opportunities by recognizing the innovative value of these companies, reinforcing them with the right team members, refueling them with the right amount of capital and redirecting them towards a realistic and meaningful exit.

Nobody else does what we do.

Contact Us to Learn More

Send us an email at info@tech-rx.vc 

 

—  Ethics Statement  —  Terms of Service  —  Privacy Policy  —  Contact Information  —
©2016 Tech-Rx Ventures LLC - All Rights Reserved

×
×
×
×
×

We rely heavily upon the breadth and depth of experience of our Advisers and Specialist Team Members.

James
Hogan


Operations and Engineering Management

Robb
Spalding


Product Management, Strategic Partnerships

Tom
Burniece


Semiconductor and
Flash Storage

Philip
Engelhardt


Finance & Angel Investing

Bob
McDonald


Executive Management, Marketing

Chris
Sorensen


Executive Management, Product-Market Fit

Theo
Keet


Executive Management, Finance, International Business

Tony
Lavia


Executive Management, Operations, Marketing and Sales

Ashish
Ahuja


Bio and Optical Engineering

Aaron
Belcher


M & A, Legal

Jonathan
Chizick


Marketing and Business Development

Jerry
Gibson


Healthcare IT, Medical Devices

Bill
Hunt


Serial Startup Expert

Jonathan
Kagan


Medical Devices

Ed
McGavin


Operations and Logistics

Theo
Priestley


Business Adviser

Howard
Rosenberg


Strategy Development

M.M. “Sath”
Sathanarayan


Offshoring

Dhaval
Shah


Business Development

Neil
Shroff


M & A, Leadership

Russ
Singleton


Medical and Healthcare Technology

Tom
Spanier


Interim CEO/CFO

Ron
Ybarra


Accounting and Finance

You can learn more about our team HERE.

×